series-c-plus
Stage
1
Investors
About
Agios Pharmaceuticals is a publicly traded biopharmaceutical company that discovers and develops novel therapies to treat cancer and rare genetic diseases by targeting cellular metabolism, with multiple approved oncology precision medicines and investigational therapies in clinical and preclinical stages.
Explore Agios Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.